Clinical Trial Update: Phase 2a Study of Efficacy and Safety of OpSCF in Moderate to Severe Atopic Dermatitis [Phase 2]

View source ↗

Summary

A Phase 2a trial is evaluating the efficacy and safety of OpSCF in adults with moderate to severe atopic dermatitis; current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• OpSCF

Snippet

Sponsor: Opsidio, LLC | Conditions: Atopic Dermatitis | Phase 2 | Status: UNKNOWN